ADC Therapeutics SA (ADCT) Earnings
|
Expand Research on ADCT
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +21.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -4.6% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/23/22 | Q222 | N/A | -$0.91 | N/A | N/A | $20.14M | N/A | N/A | N/A | ||
| 5/9/22 |  |
Q122 | -$0.36 | -$0.70 | +$0.34 | $46.5M | $28.94M | N/A |  | | Details |
| 3/3/22 | |
Q421 | -$0.39 | -$0.86 | +$0.47 | $17M | $16.46M | N/A | | | Details |
| 11/2/21 | |
Q321 | -$0.93 | -$0.92 | -$0.01 | $13.1M | $7.39M | N/A | | | Details |
| 8/3/21 | |
Q221 | -$0.95 | -$0.82 | -$0.13 | $3.76M | $2.37M | N/A | | | Details |
5/6/21  |
|
Q121 | N/A | -$0.90 | N/A | N/A | $90K | N/A | N/A | N/A | |
| 3/18/21 | |
Q420 | -$0.82 | -$0.38 | -$0.44 | N/A | $860K | N/A | | | Details |
| 11/12/20 | |
Q320 | -$0.29 | N/A | N/A | N/A | $40K | N/A | | | Details |
